Etanercept for the treatment of psoriasis and psoriatic arthritis.
about
Treatment of psoriatic arthritis with etanercept, a tumour necrosis factor antagonist.A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis.Etanercept: an introduction.Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: efficacy, safety and impact on patients' quality of life.
P2860
Etanercept for the treatment of psoriasis and psoriatic arthritis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Etanercept for the treatment of psoriasis and psoriatic arthritis.
@ast
Etanercept for the treatment of psoriasis and psoriatic arthritis.
@en
type
label
Etanercept for the treatment of psoriasis and psoriatic arthritis.
@ast
Etanercept for the treatment of psoriasis and psoriatic arthritis.
@en
prefLabel
Etanercept for the treatment of psoriasis and psoriatic arthritis.
@ast
Etanercept for the treatment of psoriasis and psoriatic arthritis.
@en
P2860
P1433
P1476
Etanercept for the treatment of psoriasis and psoriatic arthritis.
@en
P2093
Alice B Gottlieb
P2860
P304
P356
10.1111/J.1396-0296.2004.04043.X
P577
2004-01-01T00:00:00Z